Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : TOP 10 1998 Stock Picks -- Ignore unavailable to you. Want to Upgrade?

To: Al Sinopoli who wrote (1)	1/1/1998 8:24:00 PM
From: Superhawk	Read Replies (1) \| Respond to of 65

Al: Great idea. Should be fun. Can we do shorts?

To: Al Sinopoli who wrote (1)	1/3/1998 11:13:00 PM
From: John McCarthy	Read Replies (2) \| Respond to of 65

Hi Al - Great idea. OsteoArthritis Market - 16,000,000 Potential Users - 7,000,000 --------------------- (1) BIOX (30) - Product:Synvisc Product Revenue: From a couple of mil to $40.0 - $50.0 mil. Marketed by AHP (Paid $25.0 mil. license fee) Marketed by Bayer, BI, Roche, and RPR in foreign countries. See post #175 on BIOX. OsteoArthritis Market - 16,000,000 Potential Users - 7,000,000 --------------------- (2) ANIK (10) - Product:Orthovisc - Revenues: $10 mil. (1/4 Yr sales) To be Marketed by BMY BMY will pay $23.0 mil. to license. Has not cleared FDA. Competitor to BIOX BPH Market - 30 million Worldwide Potential Users - Not Sure - Over 15 million --------------------- (3) VIDA (4.50) - Product:Tuna - 1998 Revenues: $14 mil. The year 1997 was the year of get all the codes for healthcare and medicare and teach doctors to spell TUNA. The learning curve is over. Revenue should almost double from $8.0 to $14.0 mil. Product much cheaper than competition and they are making some headway with HMO's. Secondary hyperparathyroidism associated with end-stage renal disease Potential Users - ??? --------------------- (4) BCII (10) - Product: One Alpha-D2 (5) CERS (22) Regards, John McCarthy